# Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin

> **NCT00169624** · PHASE3 · TERMINATED · sponsor: **Hospices Civils de Lyon** · enrollment: 30 (—)

## Conditions studied

- Coronary and Peripheral Endothelial Dysfunction

## Interventions

- **DRUG:** Metformin
- **DRUG:** Gliclazide

## Key facts

- **NCT ID:** NCT00169624
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169624, "Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00169624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*